Business Wire

KUBESPHERE

27.5.2021 09:50:06 CEST | Business Wire | Press release

Share
Managing Kubernetes at the Edge: KubeSphere Container Platform 3.1 General Availability

KubeSphere Community announced the general availability of KubeSphere v3.1.0. KubeSphere, as an app-centric distributed operating system running on top of Kubernetes, has further expanded its portfolio to deliver more robust experiences for users across the globe, enabling DevOps teams to run Kubernetes workloads where and when they want with ease and security.

“KubeSphere has emerged as one of the most popular Kubernetes platforms ,” said Ray Zhou, Head of the KubeSphere project. “The release of KubeSphere 3.1 marks an important milestone as we further empower enterprises to gain first-mover advantages especially in edge computing.”

Taking Kubernetes From Hybrid Multi-Cloud to Edge

KubeSphere v3.1.0 provides an enabling environment for users as they can deploy production workloads not just across clouds but also at the edge . Besides, the new Metering and Billing function helps IT administrators better understand infrastructure operating costs. Existing features of multi-cluster management , multi-tenant management, observability, DevOps, application lifecycle management , and microservices governance have also been enhanced to ensure better user experiences across clusters and clouds .

Major updates include:

  • Metering and billing to track infrastructure cost
  • Edge node management for orchestrating apps and edge devices
  • Lightweight Kubernetes multi-cloud and multi-cluster management
  • Unified Kubernetes monitoring in one dashboard
  • Easier Kubernetes installation
  • Enhanced security with authentication and multi-tenancy

A full list of new features can be found in Release Note 3.1.0 . For a detailed introduction and interpretation, check out the latest KubeSphere 3.1.0 announcement

Commitment to Open-Source and Community

KubeSphere is making great strides on its international journey with over 100,000 downloads across 90 countries and regions to date. The KubeSphere console currently supports four official languages - English, Simplified Chinese, Traditional Chinese and Spanish.

“When you take a step back and reflect on how far KubeSphere has come, it is not surprising to find that it has become one of the most widely used container platforms not just in our country, but also around the world,” Ray added. “Our contributors from all corners of the world have shown us what open source is all about. And this is exactly what has been driving us to push the limits of what’s possible with Kubernetes.”

KubeSphere v3.1.0 remains committed to fully open source with an ever-expanding ecosystem, also helps developers to deploy code with several clicks on the friendly console, and brings integrated observability and powerful Kubernetes DevOps strategies for the Ops team.

About KubeSphere

KubeSphere is an open-source container platform based on Kubernetes. It provides full-stack IT automated operation and streamlined DevOps workflows. KubeSphere offers wizard web UI and enterprise-grade features for operation and maintenance, including multi-cloud and multi-cluster management , DevOps (CI/CD ), application lifecycle management , service mesh , multi-tenant , observability ,storage and network , and GPU support .

For more information, visit website https://kubesphere.io , GitHub https://github.com/kubesphere/kubesphere and follow @KubeSphere on Twitter.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Duco Launches the First Agentic Operations Platform for Financial Services27.5.2026 09:20:00 CEST | Press release

Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. P

Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release

STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD

Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release

Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to

Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria

Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye